The present invention relates generally to apparatus and methods for sealing or closing passages through tissue, and more particularly to devices for sealing punctures or other openings communicating with body lumens, such as blood vessels, and to apparatus and methods for delivering or deploying such devices.
Catheterization and interventional procedures, such as angioplasty and stenting, generally are performed by inserting a hollow needle through a patient's skin and muscle tissue into the vascular system. This creates a puncture wound in a blood vessel, frequently the femoral artery, which, once the interventional procedure has been completed, needs to be closed or sealed in a suitable manner.
Procedures and devices have been proposed for accomplishing such closure which involve the use of an introducer sheath that is placed in the tract of the puncture wound following which a closure delivering device is introduced through the introducer sheath to deploy a sealing element within the tract. An indicator wire may be used to locate the edge of the tract. After the closure delivering device deploys the sealing element, the indicator wire and the device are retracted. Examples of such procedures and devices are disclosed in application Ser. No. 10/687,848, filed Oct. 17, 2003 and Ser. No. 10/850,795 filed May 21, 2004. In these procedures and devices, it would be desirable to exploit features of the patient's anatomy to optimize sealing of the puncture wound.
A method for sealing a puncture, having an edge, in a wall of a lumen of a body comprising: deploying a deployment member of a sealing device through an elastic tissue membrane adjacent the wall of the lumen and the puncture, wherein the sealing device includes a sealing element; positioning the sealing element adjacent the wall of the lumen; retracting the deployment member relative to the sealing element to stretch the tissue membrane away from the wall of the lumen; retracting the deployment member relative to the sealing element to allow the tissue membrane to engage the sealing element; and retracting the device from the body.
In a preferred embodiment of the invention, the method is performed on a puncture wound in the femoral artery. In the noted embodiment, the elastic tissue membrane is a fascia layer and may comprise a portion of the femoral sheath.
In one aspect of the invention, the sealing element is positioned between the tissue membrane and the wall of the artery lumen when the membrane engages the sealing element. Alternatively, the sealing element partially protrudes from the tissue membrane when the membrane engages the sealing element.
Preferably, the membrane retains the sealing element at a desired position adjacent the wall of the lumen. Also preferably, the tissue membrane urges the sealing element against the wall of the lumen.
In a further embodiment of the invention, the sealing device further includes an indicator wire having a distal tip; and the method further comprises the steps of extending the indicator wire out of the deployment member when the sealing device is deployed through the puncture; adjusting the position of the sealing device until the indicator wire is adjacent to the edge of the lumen puncture; and retracting the indicator wire into the device.
In another aspect of the invention, the method for sealing a puncture comprises the steps of deploying a deployment member of a sealing device through an elastic membrane adjacent the wall of the lumen and the puncture, wherein the sealing device includes a sealing element; positioning the sealing element within the lumen; withdrawing the sealing element outside the lumen adjacent the wall of the lumen; frictionally engaging the membrane with the deployment member; retracting the deployment member relative to the sealing element to stretch the membrane away from the wall of the lumen; disengaging the deployment member from the membrane; and retracting the device from the body.
In a further aspect of the invention, the method for positioning a sealing element within a puncture comprises the steps of deploying a deployment member of a sealing device through an elastic membrane adjacent the wall of the lumen and the puncture; positioning a sealing element carried by the sealing device within the lumen, partially withdrawing the sealing element from the lumen such that the sealing element is disposed partially within the lumen and partially within the puncture when the membrane is elastically displaced; retracting the deployment member to elastically displace the membrane away from the wall of the lumen; deploying the sealing element by releasing it from the sealing device; disengaging the deployment member from the membrane, wherein the membrane elastically holds the sealing member within the puncture and partially within the lumen; and retracting the device from the body.
In yet another aspect of the invention, the method for positioning a sealing element adjacent a puncture comprises the steps of deploying a deployment member of a sealing device through an elastic membrane adjacent the wall of the lumen and the puncture; positioning a sealing element carried by the sealing device adjacent the wall of the lumen, wherein the sealing element is configured to be disposed between the wall of the lumen and the membrane when the membrane is elastically displaced; retracting the deployment member to elastically displace the membrane away from the wall of the lumen; deploying the sealing element by releasing it from the sealing device; disengaging the deployment member from the membrane, wherein the membrane elastically urges the sealing member against the wall of the lumen; and retracting the device from the body.
Other systems, methods, features and advantages of the invention will be or will become apparent to one with skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features and advantages be included within this description, be within the scope of the invention, and be protected by the accompanying claims.
In order to better appreciate how the above-recited and other advantages and objects of the present inventions are obtained, a more particular description of the invention briefly described above will be rendered by reference to specific embodiments thereof, which are illustrated in the accompanying drawings. It should be noted that the components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention. Moreover, in the figures, like reference numerals designate corresponding parts throughout the different views. However, like parts do not always have like reference numerals. Moreover, all illustrations are intended to convey concepts, where relative sizes, shapes and other detailed attributes may be illustrated schematically rather than literally or precisely.
A device 100 for deploying a detachable sealing element 160 (shown in
Alternatively, in other preferred embodiments, the sealing element 160 will be made in such a manner that it will expand spontaneously or upon removal of a restraining force. In still other embodiments, the sealing element 160 can be expandable mechanically, hydraulically or pneumatically. In all such embodiments, it is preferred that the sealing element 160 be fabricated from a bioabsorbable material.
A presently preferred embodiment employs needle-weaved polyglycolic acid (PGA) fibers that degrade through chemical hydrolysis of unstable bonds in the crystalline phase to lactic acid and glycolic acid, followed by enzymatic attack and participation in the Kreb's cycle to metabolize to carbon dioxide and water. In one embodiment, sealing element 160 exhibits modest expansion in the range of approximately 0-15%.
The closure device 100 for deploying the sealing element 160 includes a tubular elongate member 1, herein referred to as the “housing,” which houses various components that will be described below. The device 100 also comprises a wire actuator 2 which is external and distal to the housing 1 and is slidably mounted and configured to actuate an indicator wire 6, as described below. Extending through the distal end of the housing 1 is a deployment tube 7 configured to be received by an introducer sheath 300 known in the art. The deployment tube 7 is slightly longer than the introducer sheath 300. The deployment tube 7 receives an indicator wire 6 (shown in
The deployment tube 7 includes an inlet port 22 in the distal section of the tube 7, configured to take in blood when exposed to a vessel, and the housing 1 includes an outlet port 23 communicatively coupled to the inlet port 22 for allowing the blood to exit outside of the puncture wound. Also extending out of the housing is a trigger 8 that preferably includes a rotary link 14 configured to deploy the detachable sealing element 160. Before operation of the closure device 100, the rotary link 14 is locked, i.e., the operator is prevented from actuating the rotary link 14 despite pressing the trigger 8, as described below.
Turning to
Also, upon substantially complete insertion, the wire actuator 2 of the device 100 is actuated by the proximal end of the sheath 300, causing the wire actuator 2 to be pushed toward the housing 1. The wire actuator 2 is mechanically coupled to the indicator wire 6 and configured to actuate the indicator wire 6 in the distal direction. Thus, as the wire actuator 2 is pushed towards the housing 1, the wire actuator 2 causes the indicator wire 6 to extend out of the distal end of the deployment tube 7. When the indicator wire 6 exits the tube 7, the distal section of the wire 6 forms into a loop 5 located adjacent the distal tip of the tube 7. The loop 5 of the wire 6 will come into contact with the vessel wall 430 near the edge 415 of the tract 410 when the device 100 and the sheath 300 are withdrawn, as shown in
Turning to
The operator is then enabled to actuate the unlocked rotary link 14 to deploy the sealing element 160 by pressing the trigger 8. Turning to
Turning to
The first and second gears 3 and 16 share an axis that is secured by a bottom plate 101. The bottom plate 101 is actuated by a trigger that includes a rotary link 14. When the trigger 8 is pressed to deploy the plug 160, the rotary link 14, which includes an arcuate gear section 15 that engages and actuates the bottom plate 101 in the proximal direction, is actuated. A tube collar 115, which is engaged to the deployment tube 7, is anchored at a distal portion of the bottom plate 101. When the bottom plate 101 is withdrawn proximally, the collar tube 115 is withdrawn as well, which in turn withdraws proximally the deployment tube 7, which deploys the plug 160. Proximally withdrawing the bottom plate 101 causes the first gear 3 to rotate along the first rack 4, which is locked in place by the wire actuator 2 engaged with the introducer sheath 300. Proximal to the wire actuator 2 is a post 116 that extends from the housing 1. When the distal portion of the closure device 100 is inserted into the lumen of the introducer sheath 300, a proximal portion of the introducer sheath 300 that defines a lip (not shown) engages the post 116, which connects and locks the closure device 100 to the introducer sheath 300. Thus, the second rack 50 is proximally withdrawn by the second gear 16, which causes the indicator wire 6 to retract substantially simultaneously with the deployment tube 7. The figures show that the first gear 3 has a smaller diameter than the second gear 16. First and second gears 3 and 16 each provide a mechanical advantage to the control of the indicator wire 6 and deployment tube 7 respectively. Preferably, the mechanical advantage regarding the indicator wire 6 is 4:1 and the mechanical advantage regarding the deployment tube 7 is 2:1. Other mechanical advantage relationships may be used e.g., 3:1 for the indicator wire 6 and 1.5:1 for the tube 7. It is preferred that the mechanical advantage for the indicator wire 6 be twice that for the tube 7. Thus, when trigger 8 is depressed, the bottom plate 101 and tube collar 115 will withdraw the tube 7 more slowly than the indicator wire 6 is withdrawn into the device 100 and the indicator wire 6 will be retracted into the deployment tube 7 before the sealing element 160 is deployed and/or disengaged from the tube 7 and the device 100. As described above, this advantageously prevents the indicator wire 6 from interfering with the deployment of the sealing element 160.
One of ordinary skill in the art will appreciate that though a rack and pinion system is described and shown in
The housing 1 can also include an indicator assembly 200 coupled to a stationary top plate 150 of the device 100. The indicator assembly 200 can indicate to the operator, via an indicator panel 13 in the top plate 150, whether the distal end of the deployment tube 7 is in the desired location, e.g., near the edge 415 of the tract 410 of the puncture wound. In addition to, or in the alternative, the indicator assembly 200 may further lock the trigger 8 until the deployment tube 7 is in the desired location. In
Turning to
During operation, after the indicator wire 6 has been deployed through the puncture wound 400 with the formed loop 5 exposed to the lumen 420 of a vessel defined by a vessel wall 430, the operator is then ready to withdraw the device 100 and sheath 300 to deploy the sealing element 160 within the tract 410 of the puncture wound 400. Even if blood stops flowing out of the outlet port 23, that only indicates that the inlet port 22 is within the tract 410, not necessarily that the sealing element 160 is desirably near the edge 415 of the tract 410. However, the indicator wire 6 may provide such an indication. When the loop 5 of the wire 6 approaches the edge 415 of the tract 410, the loop 5 will engage the vessel wall 430 near the edge 415 as the device 100 is withdrawn by the operator. When the loop 5 engages the vessel wall 430, it will cause a force to be applied on the wire 6 toward the distal direction, or direction opposite that of the device 100 as its being withdrawn. This force will overcome the force of the spring 19 securing the lockout plate 17, proximally withdraw the lockout plate 17 in the distal direction, and cause the lockout plate 17 to disengage from the groove 18 of the rotary link 14, thereby unlocking the trigger 8. When the trigger 8 is unlocked, because the loop 5 has caught the edge 415, the distal end of the tube 7 is substantially adjacent to the edge 415 of the tract 410, which is a desirable location for the deployment of the sealing element 160. The operator is then enabled to deploy the sealing element 160.
Even though a spring loaded system is described above for locking and unlocking the trigger 8, one of ordinary skill in the art would appreciate that any locking mechanism may be employed in accordance with an embodiment of the present invention, such as a hydraulic and/or electronic system.
In addition to locking and unlocking the trigger 8, the indicator assembly 200 may also provide a visual and/or audio notification to the operator that the distal end of the tube 7 is in a desirable position. As will be explained in more detail with regard to
One of ordinary skill in the art would appreciate that though windows 21 are described, the indicator panel 21 may also utilize other mechanisms, such as electronic circuitry, light emitted diodes (LED), and/or other visual and/or audio mechanisms known in the art. For example, the device 100 may be configured such that when the indicator wire 6 engages the vessel wall 430 near the edge 415 of the tract 410, a circuit (not shown) is triggered within the housing 1 that causes a light to be emitted and/or an audio alarm to be invoked.
One of ordinary skill in the art would also appreciate that features of the anatomy of the patient's tissue can cooperate with the sealing element to facilitate the closure procedure. Preferably, the procedures of the invention position sealing element 160 so that structures located in the tissue between the patient's skin and the vessel wall 430 engage sealing element 160 and retain it against edge 415 of vessel wall 430.
For example, the transversalis fascia and the iliac fascia surround the femoral artery, forming the femoral sheath. In this region, the fasciae are relatively thick, fibrous and elastic membranes. As a result, penetration of the fasciae tend to involve a smaller puncture followed by the expansion of the hole in the fasciae to accommodate the size of the instrument forming the puncture. Upon withdrawal of the instrument, the elastic nature of the fasciae will tend to return the hole to a smaller size than the original puncture.
As can be seen in
Alternatively,
In addition to the interaction with the fascia 440, sealing element 160 is also stabilized and retained in position by other factors, including contraction of tissue above the tract.
The procedures of the invention have successfully been used to seal femoral arteriotomies. In one clinical study, average time to hemostasis using the inventive procedure averaged 138±42 sec, with patients undergoing diagnostic catheterization achieving hemostasis in 138±46 sec (45-296 sec) and patients undergoing percutaneous coronary interventions achieving hemostatis in 139±36 sec (36-245 sec) in 42 successful procedures. Notably, 83% of the patients achieved hemostasis by 2 min. Within the same study, average time to ambulation averaged 2.8 hours, with patients undergoing diagnostic catheterization ambulating in 2.78±1.23 hours (0.98-7.02 hours) and patients undergoing percutaneous coronary interventions ambulating in 2.93±1.22 hours (2.17-6.32 hours). In this study, 92% of the patients ambulated within 4 hours. The noted study experienced a 97% success rate (36/37) excluding roll-ins, where hemostasis was achieved within 5 min of plug delivery without closure-related serious adverse effects. Overall, 42 closures were achieved in 47 patients. In the study, no device-related serious adverse effects, including death, stroke, surgical repair, infection requiring hospitalization or bleeding requiring transfusion, were observed and one non-device related effect, a myocardial infarction occurred.
In the foregoing specification, the invention has been described with reference to specific embodiments thereof. It will, however, be evident that various modifications and changes may be made thereto without departing from the broader spirit and scope of the invention. For example, preferred embodiments of the invention are directed to sealing femoral arteriotomies and reference is made to the fasciae surround the femoral artery, the femoral sheath. However, the invention can be applied to other lumens and membranes in the body as desired. Further, the reader is to understand that the specific ordering and combination of process actions described herein is merely illustrative, and the invention can be performed using different or additional process actions, or a different combination or ordering of process actions. As a further example, each feature of one embodiment can be mixed and matched with other features shown in other embodiments. Additionally and obviously, features may be added or subtracted as desired. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents.
This application is a divisional application of U.S. patent application Ser. No. 12/102,728 filed Apr. 14, 2008, which claims the benefit of U.S. Provisional Application Ser. No. 60/997,461 filed on Oct. 7, 2007 and is a continuation-in-part of U.S. patent application Ser. No. 11/244,944 filed on Oct. 5, 2005, which claims the benefit of U.S. Provisional Application Ser. No. 60/677,859, filed May 4, 2005. This application is related to U.S. patent application Ser. No. 10/687,848 filed Oct. 17, 2003 and U.S. patent application Ser. No. 10/850,795, filed May 21, 2004, the disclosures of which are incorporated in their entirety herein.
Number | Name | Date | Kind |
---|---|---|---|
287046 | Norton | Oct 1883 | A |
2969887 | Darmstadt et al. | Jan 1961 | A |
3015403 | Fuller | Jan 1962 | A |
3678158 | Sussman | Jul 1972 | A |
3683655 | White et al. | Aug 1972 | A |
3757783 | Alley | Sep 1973 | A |
3875595 | Froning | Apr 1975 | A |
3941127 | Froning | Mar 1976 | A |
3944114 | Coppens | Mar 1976 | A |
3952377 | Morell | Apr 1976 | A |
3964480 | Froning | Jun 1976 | A |
4269174 | Adair | May 1981 | A |
4301802 | Poler | Nov 1981 | A |
4439423 | Smith | Mar 1984 | A |
4447915 | Weber | May 1984 | A |
4509233 | Shaw | Apr 1985 | A |
4525157 | Vaillancourt | Jun 1985 | A |
4586502 | Bedi et al. | May 1986 | A |
4638799 | Moore | Jan 1987 | A |
4719108 | Smith | Jan 1988 | A |
4738658 | Magro et al. | Apr 1988 | A |
4741330 | Hayhurst | May 1988 | A |
4741336 | Failla et al. | May 1988 | A |
4744364 | Kensey | May 1988 | A |
4772287 | Ray et al. | Sep 1988 | A |
4802478 | Powell | Feb 1989 | A |
4852568 | Kensey | Aug 1989 | A |
4863477 | Monson | Sep 1989 | A |
4878893 | Chin | Nov 1989 | A |
4878915 | Brantigan | Nov 1989 | A |
4890612 | Kensey | Jan 1990 | A |
4904260 | Ray et al. | Feb 1990 | A |
4968298 | Michelson | Nov 1990 | A |
4998934 | Bernstein | Mar 1991 | A |
5002557 | Hasson | Mar 1991 | A |
5015247 | Michelson | May 1991 | A |
5032125 | Durham et al. | Jul 1991 | A |
5061274 | Kensey | Oct 1991 | A |
5108420 | Marks | Apr 1992 | A |
5114032 | Laidlaw | May 1992 | A |
5123926 | Pisharodi | Jun 1992 | A |
5190050 | Nitzsche | Mar 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5232451 | Freitas et al. | Aug 1993 | A |
5258042 | Mehta | Nov 1993 | A |
5290310 | Makower et al. | Mar 1994 | A |
5306234 | Johnson | Apr 1994 | A |
5306254 | Nash et al. | Apr 1994 | A |
5312435 | Nash et al. | May 1994 | A |
5318525 | West et al. | Jun 1994 | A |
5334216 | Vidal et al. | Aug 1994 | A |
5334217 | Das | Aug 1994 | A |
5342393 | Stack | Aug 1994 | A |
5383852 | Stevens-Wright | Jan 1995 | A |
5383905 | Golds et al. | Jan 1995 | A |
5411520 | Nash et al. | May 1995 | A |
5425757 | Tiefenbrun et al. | Jun 1995 | A |
5443481 | Lee | Aug 1995 | A |
5486195 | Myers et al. | Jan 1996 | A |
5492763 | Barry et al. | Feb 1996 | A |
5522840 | Krajicek | Jun 1996 | A |
5531759 | Kensey et al. | Jul 1996 | A |
5549633 | Evans et al. | Aug 1996 | A |
5549679 | Kuslich | Aug 1996 | A |
5554162 | Delange | Sep 1996 | A |
5562736 | Ray et al. | Oct 1996 | A |
5571181 | Li | Nov 1996 | A |
5571189 | Kuslich | Nov 1996 | A |
5573994 | Kabra et al. | Nov 1996 | A |
5588424 | Insler et al. | Dec 1996 | A |
5588992 | Scott et al. | Dec 1996 | A |
5591206 | Moufarrege | Jan 1997 | A |
5601556 | Pisharodi | Feb 1997 | A |
5674296 | Bryan et al. | Oct 1997 | A |
5676689 | Kensey et al. | Oct 1997 | A |
5681334 | Evans et al. | Oct 1997 | A |
5690674 | Diaz | Nov 1997 | A |
5702421 | Schneidt | Dec 1997 | A |
5707352 | Sekins et al. | Jan 1998 | A |
5713911 | Racenet | Feb 1998 | A |
5720748 | Kuslich et al. | Feb 1998 | A |
5725554 | Simon et al. | Mar 1998 | A |
5728116 | Rosenman | Mar 1998 | A |
5728122 | Leschinsky et al. | Mar 1998 | A |
5728132 | Van Tassel et al. | Mar 1998 | A |
5728146 | Burkett et al. | Mar 1998 | A |
5741429 | Donadio, III et al. | Apr 1998 | A |
5800549 | Bao et al. | Sep 1998 | A |
5800550 | Sertich | Sep 1998 | A |
5814062 | Sepetka et al. | Sep 1998 | A |
5830125 | Scribner et al. | Nov 1998 | A |
5830171 | Wallace | Nov 1998 | A |
5843124 | Hammerslag | Dec 1998 | A |
5853422 | Huebsch et al. | Dec 1998 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5857999 | Quick et al. | Jan 1999 | A |
5861004 | Kensey et al. | Jan 1999 | A |
5865846 | Bryan et al. | Feb 1999 | A |
5871474 | Hermann et al. | Feb 1999 | A |
5871525 | Edwards et al. | Feb 1999 | A |
5879366 | Shaw et al. | Mar 1999 | A |
5888220 | Felt et al. | Mar 1999 | A |
5888223 | Bray, Jr. | Mar 1999 | A |
5888224 | Beckers et al. | Mar 1999 | A |
5893856 | Jacob et al. | Apr 1999 | A |
5893890 | Pisharodi | Apr 1999 | A |
5895411 | Irie | Apr 1999 | A |
5897593 | Kohrs et al. | Apr 1999 | A |
5904648 | Arndt et al. | May 1999 | A |
5906631 | Imran | May 1999 | A |
5908428 | Scirica et al. | Jun 1999 | A |
5919200 | Stambaugh et al. | Jul 1999 | A |
5941899 | Granger et al. | Aug 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5954636 | Schwartz et al. | Sep 1999 | A |
5954766 | Zadno-Azizi et al. | Sep 1999 | A |
5964807 | Gan et al. | Oct 1999 | A |
5972015 | Scribner et al. | Oct 1999 | A |
5972031 | Biedermann et al. | Oct 1999 | A |
5984927 | Wenstrom, Jr. et al. | Nov 1999 | A |
5989230 | Frassica | Nov 1999 | A |
6001130 | Bryan et al. | Dec 1999 | A |
6003517 | Sheffield et al. | Dec 1999 | A |
6007563 | Nash et al. | Dec 1999 | A |
6007570 | Sharkey et al. | Dec 1999 | A |
6013052 | Durman et al. | Jan 2000 | A |
6016806 | Webb | Jan 2000 | A |
6020380 | Killian | Feb 2000 | A |
6022376 | Assell et al. | Feb 2000 | A |
6027525 | Suh et al. | Feb 2000 | A |
6030442 | Kabra et al. | Feb 2000 | A |
6033427 | Lee | Mar 2000 | A |
6036720 | Abrams et al. | Mar 2000 | A |
6048346 | Reiley et al. | Apr 2000 | A |
6056749 | Kuslich | May 2000 | A |
6066108 | Lundberg | May 2000 | A |
6066154 | Reiley et al. | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6077281 | Das | Jun 2000 | A |
6077291 | Das | Jun 2000 | A |
6080182 | Shaw et al. | Jun 2000 | A |
6082362 | Webb | Jul 2000 | A |
6086608 | Ek et al. | Jul 2000 | A |
6093207 | Pisharodi | Jul 2000 | A |
6095149 | Sharkey et al. | Aug 2000 | A |
6099567 | Badylak et al. | Aug 2000 | A |
6122549 | Sharkey et al. | Sep 2000 | A |
6126675 | Shchervinsky et al. | Oct 2000 | A |
6126682 | Sharkey et al. | Oct 2000 | A |
6143004 | Davis et al. | Nov 2000 | A |
6146380 | Racz et al. | Nov 2000 | A |
6146419 | Eaton | Nov 2000 | A |
6156067 | Bryan et al. | Dec 2000 | A |
6174322 | Schneidt | Jan 2001 | B1 |
6174323 | Biggs et al. | Jan 2001 | B1 |
6183518 | Ross et al. | Feb 2001 | B1 |
6197042 | Ginn et al. | Mar 2001 | B1 |
6206907 | Marino et al. | Mar 2001 | B1 |
6206921 | Guagliano et al. | Mar 2001 | B1 |
6206922 | Zdeblich et al. | Mar 2001 | B1 |
6206923 | Boyd et al. | Mar 2001 | B1 |
6221109 | Geistlich et al. | Apr 2001 | B1 |
6231561 | Frazier et al. | May 2001 | B1 |
6240849 | Holler | Jun 2001 | B1 |
6248131 | Felt et al. | Jun 2001 | B1 |
6258100 | Alferness et al. | Jul 2001 | B1 |
6270515 | Linden et al. | Aug 2001 | B1 |
6287290 | Perkins et al. | Sep 2001 | B1 |
6290674 | Roue et al. | Sep 2001 | B1 |
6293951 | Alferness et al. | Sep 2001 | B1 |
6296657 | Brucker | Oct 2001 | B1 |
6306114 | Freeman et al. | Oct 2001 | B1 |
6319263 | Levinson | Nov 2001 | B1 |
6327505 | Medhkour et al. | Dec 2001 | B1 |
6346112 | Adams | Feb 2002 | B2 |
6348064 | Kanner | Feb 2002 | B1 |
6379368 | Corcoran et al. | Apr 2002 | B1 |
6447539 | Nelson et al. | Sep 2002 | B1 |
6458100 | Roue et al. | Oct 2002 | B2 |
6464645 | Park et al. | Oct 2002 | B1 |
6482224 | Michler et al. | Nov 2002 | B1 |
6482235 | Lambrecht et al. | Nov 2002 | B1 |
6494848 | Sommercorn et al. | Dec 2002 | B1 |
6517559 | O'Connell | Feb 2003 | B1 |
6547810 | Sharkey et al. | Apr 2003 | B1 |
6554833 | Levy et al. | Apr 2003 | B2 |
6626918 | Ginn et al. | Sep 2003 | B1 |
6645225 | Atkinson | Nov 2003 | B1 |
6656206 | Corcoran et al. | Dec 2003 | B2 |
6663655 | Ginn et al. | Dec 2003 | B2 |
6682489 | Tenerz et al. | Jan 2004 | B2 |
6695867 | Ginn et al. | Feb 2004 | B2 |
6699261 | Cates et al. | Mar 2004 | B1 |
6702835 | Ginn | Mar 2004 | B2 |
6776784 | Ginn | Aug 2004 | B2 |
6846319 | Ginn et al. | Jan 2005 | B2 |
6860895 | Akerfeldt et al. | Mar 2005 | B1 |
7144411 | Ginn et al. | Dec 2006 | B2 |
7317951 | Schneider et al. | Jan 2008 | B2 |
7361183 | Ginn | Apr 2008 | B2 |
20010003158 | Kensey et al. | Jun 2001 | A1 |
20010037808 | Deem et al. | Nov 2001 | A1 |
20010052344 | Doshi | Dec 2001 | A1 |
20020002386 | Ginn et al. | Jan 2002 | A1 |
20020016583 | Cragg | Feb 2002 | A1 |
20020022822 | Cragg et al. | Feb 2002 | A1 |
20020072767 | Zhu | Jun 2002 | A1 |
20020077656 | Ginn et al. | Jun 2002 | A1 |
20020077657 | Ginn et al. | Jun 2002 | A1 |
20020077658 | Ginn | Jun 2002 | A1 |
20020077701 | Kuslich | Jun 2002 | A1 |
20020095179 | Tenerz et al. | Jul 2002 | A1 |
20020112729 | DeVore et al. | Aug 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20030023267 | Ginn | Jan 2003 | A1 |
20030033006 | Phillips et al. | Feb 2003 | A1 |
20030045893 | Ginn | Mar 2003 | A1 |
20030050665 | Ginn | Mar 2003 | A1 |
20030088271 | Cragg et al. | May 2003 | A1 |
20030139819 | Beer et al. | Jul 2003 | A1 |
20030144694 | Chanduszko et al. | Jul 2003 | A1 |
20030145865 | Sterman et al. | Aug 2003 | A1 |
20030208232 | Blaeser et al. | Nov 2003 | A1 |
20030225421 | Peavey et al. | Dec 2003 | A1 |
20040059375 | Ginn et al. | Mar 2004 | A1 |
20040073242 | Chanduszko | Apr 2004 | A1 |
20040098042 | Devellian et al. | May 2004 | A1 |
20040098121 | Opolski | May 2004 | A1 |
20040133236 | Chanduszko | Jul 2004 | A1 |
20050085854 | Ginn | Apr 2005 | A1 |
20050192606 | Paul et al. | Sep 2005 | A1 |
20050267528 | Ginn | Dec 2005 | A1 |
Number | Date | Country |
---|---|---|
3922203 | Oct 1990 | DE |
19710392 | Jul 1999 | DE |
0432321 | Jun 1991 | EP |
0700671 | Mar 1996 | EP |
1033115 | Sep 2000 | EP |
1078601 | Feb 2001 | EP |
2639823 | Jun 1990 | FR |
WO 9205828 | Apr 1992 | WO |
WO 9726847 | Jul 1997 | WO |
WO 9802100 | Jan 1998 | WO |
WO 9819605 | May 1998 | WO |
WO 9820939 | May 1998 | WO |
WO 9848706 | Nov 1998 | WO |
WO 9902100 | Jan 1999 | WO |
WO 9902108 | Jan 1999 | WO |
WO 9902214 | Jan 1999 | WO |
WO 9961084 | Dec 1999 | WO |
WO 9965544 | Dec 1999 | WO |
WO 0007506 | Feb 2000 | WO |
WO 0062699 | Oct 2000 | WO |
WO 0069374 | Nov 2000 | WO |
WO 0071032 | Nov 2000 | WO |
WO 0102042 | Jan 2001 | WO |
WO 0110316 | Feb 2001 | WO |
WO 0113839 | Mar 2001 | WO |
WO 0113908 | Mar 2001 | WO |
WO 0121247 | Mar 2001 | WO |
WO 0126588 | Apr 2001 | WO |
WO 0128464 | Apr 2001 | WO |
WO 0145577 | Jun 2001 | WO |
WO 0145579 | Jun 2001 | WO |
WO 0160288 | Aug 2001 | WO |
WO 0166045 | Sep 2001 | WO |
WO 0166190 | Sep 2001 | WO |
WO 0187170 | Nov 2001 | WO |
Entry |
---|
E.H. Cassinelli, M.D., et al., “Biochemistry of Intervertebral Disc Degeneration and the Potential for Gene Therapy Applications”, SpineLine, The Clinical & News Magazine for Spine Care Professionals, vol. 11, Issue 1, Jan.-Feb. 2001. |
K. Nishimura, M.D., et al., “Percutaneous Reinsertion of the Nucleus Pulposus, An Experimental Study”, SPINE vol. 23, No. 14, pp. 1531-1539, 1998. |
Maurice Hiles, “New Specialty Polymer Products Through Interpenetrating Polymer Network (IPN) Technology—The Development of an Interpenetrating Polymer Network to Contain Mechanically Induced Vibration”, Oct. 20-21, 1986, Colony Square Hotel, Atlanta, GA. |
Zoltan G. Turi, M.D., “Overview of Vascular Closure”, Endovascular Today, Closure Update 2008, pp. 28-37. |
Number | Date | Country | |
---|---|---|---|
20150080946 A1 | Mar 2015 | US |
Number | Date | Country | |
---|---|---|---|
60677859 | May 2005 | US | |
60997461 | Oct 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12102728 | Apr 2008 | US |
Child | 14548000 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11244944 | Oct 2005 | US |
Child | 12102728 | US |